Mutations in SKI in Shprintzen-Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
08 01 2021
Historique:
received: 28 09 2020
accepted: 07 01 2021
pubmed: 9 1 2021
medline: 29 1 2022
entrez: 8 1 2021
Statut: epublish

Résumé

Shprintzen-Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys-Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.

Identifiants

pubmed: 33416497
doi: 10.7554/eLife.63545
pii: 63545
pmc: PMC7834018
doi:
pii:

Substances chimiques

DNA-Binding Proteins 0
Proto-Oncogene Proteins 0
Transforming Growth Factor beta 0
SKI protein, human 126648-96-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : FC001095
Pays : United Kingdom
Organisme : Cancer Research UK
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

© 2021, Gori et al.

Déclaration de conflit d'intérêts

IG, RG, AP, SS, RR, RO, VC, LF, DJ, SK, CH No competing interests declared

Références

Science. 1999 Oct 22;286(5440):771-4
pubmed: 10531062
Toxicol Pathol. 2011 Oct;39(6):916-24
pubmed: 21859884
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30
pubmed: 22992590
Cold Spring Harb Perspect Biol. 2016 Jun 01;8(6):
pubmed: 27252363
Mol Pharmacol. 2002 Jul;62(1):65-74
pubmed: 12065756
Science. 2006 Apr 7;312(5770):117-21
pubmed: 16601194
Cell. 2002 Nov 1;111(3):357-67
pubmed: 12419246
Toxicol Sci. 2020 May 1;175(1):24-34
pubmed: 32077954
Mol Cell Biol. 2000 Dec;20(23):9041-54
pubmed: 11074002
Nature. 1997 Jul 3;388(6637):87-93
pubmed: 9214508
Eur J Med Genet. 2015 Dec;58(12):695-703
pubmed: 26598797
Nat Genet. 2012 Jul 08;44(8):922-7
pubmed: 22772368
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
J Clin Invest. 2014 Jan;124(1):448-60
pubmed: 24355923
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67
pubmed: 21460454
Mol Cell Biol. 2007 Sep;27(17):6068-83
pubmed: 17591695
Science. 2011 Apr 15;332(6027):358-61
pubmed: 21493862
Genome Biol. 2014;15(12):550
pubmed: 25516281
Matrix Biol. 2018 Oct;71-72:90-99
pubmed: 29217273
J Am Heart Assoc. 2017 Jan 24;6(1):
pubmed: 28119285
Hum Mutat. 2016 Jun;37(6):524-31
pubmed: 26919284
Nat Methods. 2006 Dec;3(12):1021-32
pubmed: 17117155
J Biol Chem. 2001 Jun 8;276(23):19945-53
pubmed: 11262418
Science. 2000 Jan 7;287(5450):92-7
pubmed: 10615055
Cancer Res. 2008 May 1;68(9):3277-85
pubmed: 18451154
EMBO J. 2002 Jan 15;21(1-2):145-56
pubmed: 11782434
Physiol Genomics. 2004 Oct 4;19(2):151-4
pubmed: 15466717
Elife. 2018 Jan 29;7:
pubmed: 29376829
Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):911-7
pubmed: 25614286
Cell Tissue Res. 2012 Jan;347(1):51-64
pubmed: 21647564
Sci Signal. 2018 Mar 27;11(523):
pubmed: 29588413
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12442-7
pubmed: 10535941
EMBO J. 1998 Jun 1;17(11):3091-100
pubmed: 9606191
Mol Cell Biol. 2004 Feb;24(3):1106-21
pubmed: 14729957
Nat Genet. 2003 Mar;33(3):407-11
pubmed: 12598898
Sci Rep. 2017 Apr 11;7:46370
pubmed: 28397834
J Cell Sci. 2004 Aug 15;117(Pt 18):4113-25
pubmed: 15280432
JAMA. 1989 Jul 28;262(4):523-8
pubmed: 2739055
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
J Recept Signal Transduct Res. 2012 Jun;32(3):150-5
pubmed: 22414221
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Mol Cell Biol. 1999 Mar;19(3):1821-30
pubmed: 10022869
J Biol Chem. 2007 Jul 13;282(28):20492-501
pubmed: 17510063
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nat Genet. 2005 Mar;37(3):275-81
pubmed: 15731757
Cell Res. 2009 Jan;19(1):47-57
pubmed: 19114989
Biochem J. 2004 Apr 1;379(Pt 1):209-16
pubmed: 14715079
Clin Genet. 2015;87(1):11-20
pubmed: 24867163
Elife. 2021 Jan 08;10:
pubmed: 33416497
Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):2102-2113
pubmed: 28729364
Ann Thorac Surg. 2007 Feb;83(2):S757-63; discussion S785-90
pubmed: 17257922
Mol Cell Biol. 2012 Jul;32(14):2904-16
pubmed: 22615489
J Clin Invest. 2019 Feb 1;129(2):659-675
pubmed: 30614814
J Biol Chem. 1999 Feb 19;274(8):4485-8
pubmed: 9988677
Nature. 2017 Feb 2;542(7639):55-59
pubmed: 28117447
Acta Crystallogr D Biol Crystallogr. 2012 Apr;68(Pt 4):352-67
pubmed: 22505256
Nature. 1991 Jul 25;352(6333):337-9
pubmed: 1852208
J Biol Chem. 2003 Aug 29;278(35):32489-92
pubmed: 12857746
Acta Crystallogr D Struct Biol. 2019 Oct 1;75(Pt 10):861-877
pubmed: 31588918
Structure. 2004 May;12(5):785-92
pubmed: 15130471
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Cell. 2001 Dec;8(6):1277-89
pubmed: 11779503
J Biol Chem. 2002 Feb 15;277(7):4883-91
pubmed: 11729207
Eur J Hum Genet. 2015 Feb;23(2):224-8
pubmed: 24736733
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Genes Dev. 1999 Sep 1;13(17):2196-206
pubmed: 10485843
Nat Genet. 2002 Jan;30(1):106-9
pubmed: 11731796
Curr Opin Genet Dev. 2004 Feb;14(1):65-70
pubmed: 15108807
Cell Rep. 2018 Nov 13;25(7):1841-1855.e5
pubmed: 30428352
J Med Genet. 2012 Jan;49(1):47-57
pubmed: 22167769
Nat Genet. 2012 Nov;44(11):1249-54
pubmed: 23023332
Nat Genet. 2003 Mar;33(3):331-2
pubmed: 12610545
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Hum Mutat. 2018 May;39(5):621-634
pubmed: 29392890
Am J Hum Genet. 2012 Nov 2;91(5):950-7
pubmed: 23103230
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
Cancer Res. 2013 Mar 15;73(6):1800-10
pubmed: 23467611
Biochem J. 2009 Jan 1;417(1):205-12
pubmed: 18764783
Genes Dev. 1999 Feb 15;13(4):412-23
pubmed: 10049357
Comput Biol Chem. 2019 Dec;83:107159
pubmed: 31743832
J Craniofac Genet Dev Biol. 1982;2(1):65-74
pubmed: 6182156
Gene. 2013 Oct 10;528(2):352-5
pubmed: 23892090
Am J Med Genet. 1998 Mar 19;76(3):202-12
pubmed: 9508238
Matrix Biol. 2015 Sep;47:44-53
pubmed: 25960419
J Cell Sci. 2010 Dec 15;123(Pt 24):4340-50
pubmed: 21098638

Auteurs

Ilaria Gori (I)

Developmental Signalling Laboratory, The Francis Crick Institute, London, United Kingdom.

Roger George (R)

Structural Biology Facility, The Francis Crick Institute, London, United Kingdom.

Andrew G Purkiss (AG)

Structural Biology Facility, The Francis Crick Institute, London, United Kingdom.

Stephanie Strohbuecker (S)

Bioinformatics and Biostatistics Facility, The Francis Crick Institute, London, United Kingdom.

Rebecca A Randall (RA)

Developmental Signalling Laboratory, The Francis Crick Institute, London, United Kingdom.

Roksana Ogrodowicz (R)

Structural Biology Facility, The Francis Crick Institute, London, United Kingdom.

Virginie Carmignac (V)

INSERM - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.

Laurence Faivre (L)

INSERM - Université de Bourgogne UMR1231 GAD, FHU-TRANSLAD, Dijon, France.

Dhira Joshi (D)

Peptide Chemistry Facility, The Francis Crick Institute, London, United Kingdom.

Svend Kjær (S)

Structural Biology Facility, The Francis Crick Institute, London, United Kingdom.

Caroline S Hill (CS)

Developmental Signalling Laboratory, The Francis Crick Institute, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH